Cambridge Financial Group Inc. Has $5.83 Million Stake in UnitedHealth Group Inc (NYSE:UNH)

Cambridge Financial Group Inc. lessened its position in UnitedHealth Group Inc (NYSE:UNH) by 5.7% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 23,381 shares of the healthcare conglomerate’s stock after selling 1,402 shares during the period. UnitedHealth Group comprises about 3.9% of Cambridge Financial Group Inc.’s portfolio, making the stock its 6th largest holding. Cambridge Financial Group Inc.’s holdings in UnitedHealth Group were worth $5,831,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently made changes to their positions in UNH. Orser Capital Management LLC grew its position in shares of UnitedHealth Group by 16.7% in the 4th quarter. Orser Capital Management LLC now owns 700 shares of the healthcare conglomerate’s stock valued at $206,000 after acquiring an additional 100 shares during the period. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA lifted its stake in shares of UnitedHealth Group by 42.8% during the 4th quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA now owns 1,301 shares of the healthcare conglomerate’s stock worth $382,000 after buying an additional 390 shares during the last quarter. S.E.E.D. Planning Group LLC acquired a new stake in shares of UnitedHealth Group during the 4th quarter worth about $3,174,000. Patriot Financial Group Insurance Agency LLC lifted its stake in shares of UnitedHealth Group by 30.0% during the 4th quarter. Patriot Financial Group Insurance Agency LLC now owns 598 shares of the healthcare conglomerate’s stock worth $176,000 after buying an additional 138 shares during the last quarter. Finally, Country Club Trust Company n.a. lifted its stake in shares of UnitedHealth Group by 1.8% during the 4th quarter. Country Club Trust Company n.a. now owns 2,699 shares of the healthcare conglomerate’s stock worth $793,000 after buying an additional 47 shares during the last quarter. 87.10% of the stock is owned by institutional investors.

In related news, Director Richard T. Burke sold 5,000 shares of UnitedHealth Group stock in a transaction that occurred on Wednesday, March 18th. The shares were sold at an average price of $212.00, for a total transaction of $1,060,000.00. Following the sale, the director now directly owns 158,598 shares of the company’s stock, valued at approximately $33,622,776. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Richard T. Burke sold 10,000 shares of UnitedHealth Group stock in a transaction that occurred on Friday, March 20th. The shares were sold at an average price of $228.39, for a total transaction of $2,283,900.00. Following the sale, the director now directly owns 158,598 shares in the company, valued at $36,222,197.22. The disclosure for this sale can be found here. Insiders have sold a total of 65,637 shares of company stock worth $17,723,013 over the last ninety days. 0.80% of the stock is currently owned by insiders.

Shares of UnitedHealth Group stock traded up $3.03 during midday trading on Friday, hitting $289.94. 2,907,540 shares of the company traded hands, compared to its average volume of 4,276,896. The stock has a market cap of $272.10 billion, a price-to-earnings ratio of 20.29, a PEG ratio of 1.41 and a beta of 0.72. The company has a debt-to-equity ratio of 0.60, a quick ratio of 0.75 and a current ratio of 0.75. The firm’s fifty day moving average price is $277.58 and its 200-day moving average price is $277.14. UnitedHealth Group Inc has a 12 month low of $187.72 and a 12 month high of $306.71.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Wednesday, April 15th. The healthcare conglomerate reported $3.72 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.63 by $0.09. The company had revenue of $64.40 billion for the quarter, compared to analyst estimates of $64.25 billion. UnitedHealth Group had a net margin of 5.59% and a return on equity of 24.86%. The firm’s revenue was up 6.8% on a year-over-year basis. During the same period in the previous year, the firm posted $3.73 EPS. Equities research analysts forecast that UnitedHealth Group Inc will post 16.24 earnings per share for the current year.

A number of research firms have recently issued reports on UNH. Deutsche Bank cut their target price on shares of UnitedHealth Group from $308.00 to $293.00 and set a “buy” rating for the company in a research note on Thursday, April 16th. Citigroup cut their target price on shares of UnitedHealth Group from $346.00 to $339.00 and set a “buy” rating for the company in a research note on Friday, April 24th. Raymond James cut their target price on shares of UnitedHealth Group from $340.00 to $325.00 in a research note on Thursday, April 16th. Cowen lifted their price objective on shares of UnitedHealth Group from $320.00 to $340.00 and gave the stock an “outperform” rating in a research note on Thursday, April 16th. Finally, Morgan Stanley lifted their price objective on shares of UnitedHealth Group from $289.00 to $371.00 and gave the stock an “overweight” rating in a research note on Thursday, April 30th. Four investment analysts have rated the stock with a hold rating and twenty have issued a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and an average price target of $319.68.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Recommended Story: When can a hold rating present a buying opportunity?

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.